REGENCOR INC
Healing a broken heart, quite literally
San Carlos, United States · Founded 2018 · $3.9M raised
- Headquarters
- San Carlos, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- regencor.com
- Total Funding
- $3.9M
- Last Round
- $3.9M GrantNov 2021
- Rounds
- 2
About
Regencor is a regenerative medicine company developing therapeutics to repair cardiac tissue damage and restore heart function after myocardial infarction. Its lead asset REG101 (recombinant FSTL1 protein) reverses scar tissue formation and is being developed in two delivery formulations — MyoBeads for acute MI intervention and Q-Beads for subcutaneous administration in heart failure patients.
Summary
REGENCOR INC is a Biotech company based in San Carlos, United States, founded in 2018. It has raised $3.9M in total across 2 rounds, most recently a $3.9M Grant round in Nov 2021. Investors include California Institute for Regenerative Medicine (CIRM) and Amgen.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2021
Sign up to see all 2 rounds
Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/regencor-inc"><img src="https://indexed.vc/api/badge/company/regencor-inc" alt="REGENCOR INC on Indexed.vc" width="260" height="76" /></a>